Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2033-2041

  Floyd, Tamara L ^a   Koehn, Brent H ^a   Kitchens, William H ^a   Robertson, Jennifer M ^a   Cheeseman, Jennifer A ^a   Stempora, Linda ^a   Larsen, Christian P ^a   Ford, Mandy L ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CD28 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; OVALBUMIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CROSS PRESENTATION; DONOR; GRAFT RECIPIENT; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOPHENOTYPING; IMMUNOSTIMULATION; LISTERIOSIS; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT;

AMPICILLIN; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; BACTERIAL LOAD; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GRAFT VS HOST REACTION; IMMUNOLOGIC MEMORY; LISTERIOSIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; OVALBUMIN; SKIN TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 79951828813     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003015     Document Type: Article

References (52)

1. Jameson, S. C., and D. Masopust. 2009. Diversity in T cell memory: an embarrassment of riches. Immunity 31: 859-871.
2. Woodland, D. L., and J. E. Kohlmeier. 2009. Migration, maintenance and recall of memory T cells in peripheral tissues. Nat. Rev. Immunol. 9: 153-161.
3. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
4. Hikono, H., J. E. Kohlmeier, S. Takamura, S. T. Wittmer, A. D. Roberts, and D. L. Woodland. 2007. Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 204: 1625-1636.
5. London, C. A., M. P. Lodge, and A. K. Abbas. 2000. Functional responses and costimulator dependence of memory CD4+ T cells. J. Immunol. 164: 265-272.
6. Kim, S. K., K. S. Schluns, and L. Lefrançois. 1999. Induction and visualization of mucosal memory CD8 T cells following systemic virus infection. J. Immunol. 163: 4125-4132. (Pubitemid 29474474)
7. Bachmann, M. F., A. Gallimore, S. Linkert, V. Cerundolo, A. Lanzavecchia, M. Kopf, and A. Viola. 1999. Developmental regulation of Lck targeting to the CD8 coreceptor controls signaling in naive and memory T cells. J. Exp. Med. 189: 1521-1530.
8. Croft, M., L. M. Bradley, and S. L. Swain. 1994. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152: 2675-2685.
9. Suresh, M., J. K. Whitmire, L. E. Harrington, C. P. Larsen, T. C. Pearson, J. D. Altman, and R. Ahmed. 2001. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J. Immunol. 167: 5565-5573.
10. Khoury, S. J., E. Akalin, A. Chandraker, L. A. Turka, P. S. Linsley, M. H. Sayegh, and W. W. Hancock. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J. Immunol. 155: 4521-4524.
11. Bluestone, J. A., E. W. St Clair, and L. A. Turka. 2006. CTLA4Ig: bridging the basic immunology with clinical application. Immunity 24: 233-238.
12. Abrams, J. R., M. G. Lebwohl, C. A. Guzzo, B. V. Jegasothy, M. T. Goldfarb, B. S. Goffe, A. Menter, N. J. Lowe, G. Krueger, M. J. Brown, et al. 1999. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J. Clin. Invest. 103: 1243-1252.
13. Kremer, J. M., R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I. F. Nuamah, et al. 2003. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349: 1907-1915.
14. Borowski, A. B., A. C. Boesteanu, Y. M. Mueller, C. Carafides, D. J. Topham, J. D. Altman, S. R. Jennings, and P. D. Katsikis. 2007. Memory CD8+ T cells require CD28 costimulation. J. Immunol. 179: 6494-6503.
15. Ford, M. L., and C. P. Larsen. 2010. Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations. Curr. Opin. Organ Transplant. 15: 405-410.
16. Bingaman, A. W., and D. L. Farber. 2004. Memory T cells in transplantation: generation, function, and potential role in rejection. Am. J. Transplant. 4: 846-852.
17. Amir, A. L., L. J. D'Orsogna, D. L. Roelen, M. M. van Loenen, R. S. Hagedoorn, R. de Boer, M. A. van der Hoorn, M. G. Kester, I. I. Doxiadis, II, J. H. Falkenburg, et al. 2010. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115: 3146-3157.
18. Heeger, P. S., N. S. Greenspan, S. Kuhlenschmidt, C. Dejelo, D. E. Hricik, J. A. Schulak, and M. Tary-Lehmann. 1999. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol. 163: 2267-2275. (Pubitemid 29382237)
19. Vincenti, F., B. Charpentier, Y. Vanrenterghem, L. Rostaing, B. Bresnahan, P. Darji, P. Massari, G. A. Mondragon-Ramirez, M. Agarwal, G. Di Russo, et al. 2010. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10: 535-546.
20. Vincenti, F., C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, G. Blancho, P. Lang, J. Grinyo, P. F. Halloran, K. Solez, et al; Belatacept Study Group. 2005. Costimulation blockade with belatacept in renal transplantation. N. Engl. J. Med. 353: 770-781.
21. Durrbach, A., J. M. Pestana, T. Pearson, F. Vincenti, V. D. Garcia, J. Campistol, Mdel. C. Rial, S. Florman, A. Block, G. Di Russo, et al. 2010. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am. J. Transplant. 10: 547-557.
22. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434-438. (Pubitemid 26162734)
23. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257: 792-795.
24. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, Jr., and S. J. Knechtle. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA 94: 8789-8794.
25. Neujahr, D. C., C. Chen, X. Huang, J. F. Markmann, S. Cobbold, H. Waldmann, M. H. Sayegh, W. W. Hancock, and L. A. Turka. 2006. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J. Immunol. 176: 4632-4639.
26. Pantenburg, B., F. Heinzel, L. Das, P. S. Heeger, and A. Valujskikh. 2002. T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection. J. Immunol. 169: 3686-3693.
27. Valujskikh, A., B. Pantenburg, and P. S. Heeger. 2002. Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am. J. Transplant. 2: 501-509.
28. Welsh, R. M., T. G. Markees, B. A. Woda, K. A. Daniels, M. A. Brehm, J. P. Mordes, D. L. Greiner, and A. A. Rossini. 2000. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J. Virol. 74: 2210-2218.
29. Adams, A. B., N. Shirasugi, T. R. Jones, M. A. Williams, M. M. Durham, J. Ha, Y. Dong, Z. Guo, K. A. Newell, T. C. Pearson, and C. P. Larsen. 2003. Conventional immunosuppression is compatible with costimulation blockade-based, mixed chimerism tolerance induction. Am. J. Transplant. 3: 895-901.
30. Williams, M. A., T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2002. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169: 5387-5391.
31. Valujskikh, A., and F. G. Lakkis. 2003. In remembrance of things past: memory T cells and transplant rejection. Immunol. Rev. 196: 65-74.
32. Lakkis, F. G., and M. H. Sayegh. 2003. Memory T cells: a hurdle to immunologic tolerance. J. Am. Soc. Nephrol. 14: 2402-2410.
33. Adams, A. B., M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111: 1887-1895.
34. Chen, Y., P. S. Heeger, and A. Valujskikh. 2004. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy. J. Immunol. 172: 5456-5466.
35. Sarkar, J. K., A. C. Mitra, and M. K. Mukherjee. 1975. The minimum protective level of antibodies in smallpox. Bull. World Health Organ. 52: 307-311.
36. Kalia, V., S. Sarkar, and R. Ahmed. 2008. Fine-tuning CD4+ central memory T cell heterogeneity by strength of stimulation. Eur. J. Immunol. 38: 15-19.
37. Blair, D. A., and L. Lefrançois. 2007. Increased competition for antigen during priming negatively impacts the generation of memory CD4 T cells. Proc. Natl. Acad. Sci. USA 104: 15045-15050.
38. Ehst, B. D., E. Ingulli, and M. K. Jenkins. 2003. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am. J. Transplant. 3: 1355-1362.
39. Shen, H., J. F. Miller, X. Fan, D. Kolwyck, R. Ahmed, and J. T. Harty. 1998. Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell 92: 535-545.
40. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
41. Williams, M. A., and M. J. Bevan. 2004. Shortening the infectious period does not alter expansion of CD8 T cells but diminishes their capacity to differentiate into memory cells. J. Immunol. 173: 6694-6702.
42. Kaech, S. M., and R. Ahmed. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells. Nat. Immunol. 2: 415-422.
43. Mercado, R., S. Vijh, S. E. Allen, K. Kerksiek, I. M. Pilip, and E. G. Pamer. 2000. Early programming of T cell populations responding to bacterial infection. J. Immunol. 165: 6833-6839.
44. Sarkar, S., V. Teichgräber, V. Kalia, A. Polley, D. Masopust, L. E. Harrington, R. Ahmed, and E. J. Wherry. 2007. Strength of stimulus and clonal competition impact the rate of memory CD8T cell differentiation. J. Immunol. 179: 6704-6714.
45. Kaech, S. M., J. T. Tan, E. J. Wherry, B. T. Konieczny, C. D. Surh, and R. Ahmed. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4: 1191-1198.
46. Sarkar, S., V. Kalia, W. N. Haining, B. T. Konieczny, S. Subramaniam, and R. Ahmed. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205: 625-640.
47. Marzo, A. L., K. D. Klonowski, A. Le Bon, P. Borrow, D. F. Tough, and L. Lefrançois. 2005. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6: 793-799.
48. Ford, M. L., B. H. Koehn, M. E. Wagener, W. Jiang, S. Gangappa, T. C. Pearson, and C. P. Larsen. 2007. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J. Exp. Med. 204: 299-309.
49. Oberbarnscheidt, M. H., Y. H. Ng, and G. Chalasani. 2008. The roles of CD8 central and effector memory T-cell subsets in allograft rejection. Am. J. Transplant. 8: 1809-1818.
50. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
51. Rahman, A. H., W. Cui, D. F. Larosa, D. K. Taylor, J. Zhang, D. R. Goldstein, E. J. Wherry, S. M. Kaech, and L. A. Turka. 2008. MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection. J. Immunol. 181: 3804-3810.
52. Wang, T., L. Chen, E. Ahmed, L. Ma, D. Yin, P. Zhou, J. Shen, H. Xu, C. R. Wang, M. L. Alegre, and A. S. Chong. 2008. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J. Immunol. 180: 5991-5999.